InVivo Therapeutics Holdings Corp. Stock
Equities
NVIV
US46186M6057
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3983 USD | +2.12% | +2.13% | -45.44% |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.5M |
---|---|---|---|---|---|
Net income 2021 | -9M | Net income 2022 | -10M | EV / Sales 2021 | - |
Net cash position 2021 | 17.72M | Net cash position 2022 | 15.4M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.52
x | P/E ratio 2022 |
-0.34
x | Employees | 6 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.98% |
1 day | +2.12% | ||
1 week | +2.13% | ||
1 month | +7.65% | ||
3 months | +59.26% | ||
6 months | -45.44% | ||
Current year | -45.44% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Toselli
CEO | Chief Executive Officer | 66 | 17-07-04 |
Director of Finance/CFO | 54 | 19-01-13 | |
Heather M. Hamel
LAW | General Counsel | - | 17-07-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 16-06-07 | |
Robert Rosenthal
BRD | Director/Board Member | 67 | 19-11-07 |
C. Merrifield
CHM | Chairman | 73 | 14-11-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.3983 | +2.12% | 2,460 |
24-05-30 | 0.39 | -.--% | 1,969 |
24-05-29 | 0.39 | -2.10% | 9,173 |
24-05-28 | 0.3984 | +2.15% | 2,240 |
24-05-24 | 0.39 | +5.41% | 6,723 |
Delayed Quote OTC Markets, May 31, 2024 at 02:42 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-45.44% | 1.24M | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.6B |
- Stock Market
- Equities
- NVIV Stock